By Mr Alexander Lewis Dowell-Day

Journal articles

Wells N; Richman B; Grace D; Riley B; Hui C; Vojnov L; Stackpool-Moore L; Ong JJ; Dowell-Day A; Allan B, 2024, '2023 Undetectable = Untransmittable global policy roundtable report: a multistakeholder perspective on Undetectable = Untransmittable research and policy priorities', Sexual Health, 21, pp. SH24017, http://dx.doi.org/10.1071/sh24017

Dowell-Day A; Dobbins T; Chan C; Fraser D; Holt M; Vaccher SJ; Clifton B; Zablotska I; Grulich A; Bavinton BR, 2023, 'Attitudes Towards Treatment as Prevention Among PrEP-Experienced Gay and Bisexual Men in Australia', AIDS and Behavior, 27, pp. 2969 - 2978, http://dx.doi.org/10.1007/s10461-023-04019-x

Grebely J; Tran L; Degenhardt L; Dowell-Day A; Santo T; Larney S; Hickman M; Vickerman P; French C; Butler K; Gibbs D; Valerio H; Read P; Dore GJ; Hajarizadeh B, 2021, 'Association between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection among People Who Inject Drugs: A Systematic Review and Meta-analysis', Clinical Infectious Diseases, 73, pp. E107 - E118, http://dx.doi.org/10.1093/cid/ciaa612

Seale H; Dyer CEF; Abdi I; Rahman KM; Sun Y; Qureshi MO; Dowell-Day A; Sward J; Islam MS, 2020, 'Improving the impact of non-pharmaceutical interventions during COVID-19: Examining the factors that influence engagement and the impact on individuals', BMC Infectious Diseases, 20, http://dx.doi.org/10.1186/s12879-020-05340-9

Reports

Arapali T; Warzywoda S; Smith AKJ; Keen P; Mac Phail C; Dowell-Day A; Clackett S; Sullivan E; Chan C; Hammoud MA; Holt M; Avasalu R; Grulich A; Bavinton B, 2024, Innovative oral PrEP service delivery models and the policy, legal, and regulatory barriers to their implementation, http://dx.doi.org/10.26190/4xvf-0083

Back to profile page